Related Experiment Video
Updated: Aug 30, 2025
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.0K
Nanomedicine in Cancer Targeting and Therapy
Ilaria Elena Palamà1, Stefano Leporatti1
1CNR-NANOTEC, Istituto di Nanotecnologia, Via Monteroni, 73100 Lecce, Italy.
Journal of Personalized Medicine
|August 26, 2022
Abstract:
Currently, cancer represents a major cause of death in the world, despite all the progress made in developing new therapies [...].
Insights
Cancer remains a leading global cause of death. New therapeutic strategies are urgently needed to improve patient survival rates and combat this widespread disease.
Area of Science:
- Oncology and Cancer Research
- Translational Medicine
Background:
- Cancer is a significant global health burden, driving mortality worldwide.
- Despite advancements, existing therapies face limitations in efficacy and patient outcomes.
- There is a critical need for novel therapeutic approaches to overcome treatment resistance.
Discussion:
- Exploring innovative cancer treatment modalities is essential.
- Understanding the molecular mechanisms underlying cancer progression is key.
- Developing targeted therapies can improve treatment specificity and reduce side effects.
Key Insights:
- Emerging research focuses on novel therapeutic targets.
- Investigating new drug delivery systems enhances treatment effectiveness.
- Personalized medicine approaches are showing promise in oncology.
Outlook:
- Future cancer therapies will likely involve combination treatments.
- Biomarker discovery will guide precision oncology strategies.
- Continued research aims to reduce cancer-related morbidity and mortality.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Tumor Immunotherapy
644
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
644